← Devices & Neurotechnology
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
National Taiwan Genetic Screening Study of Age-Related Hearing Loss
Also known as: Genetic Study of Age Related Hearing Loss, genes, Draw blood for genetic screening, Presbycusis, NCT01732289
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Diagnostic
Modality
Diagnostic
Stage
Early Phase 1
Status
Completed
Target Gene
—
Route / Mode
Blood draw for genetic screening
Confidence
84%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
Taiwan
Population
adult, age-related, genetic, diagnostic
Trial IDs
1
Mechanism
Completed genetic screening/blood-draw study in age-related hearing loss and presbycusis; the registry intervention is genetic testing, not gene therapy.
Indications
Notes
Corrected from a misleading gene-therapy therapeutic row to a diagnostic/genetic screening study. This is not an interventional gene therapy program.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, aliases, company, allCompanies, isIndustrySponsored, programType, modality, mechanism...
IDs: NCT01732289
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-only-evidencediagnostic-study-not-productnatural-history-study-not-therapyhistorical-study
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
MED-EL SYNCHRONY Cochlear Implant System
Company: MED-EL · Cochlear/Auditory Implant · Marketed
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed